11 companies

Zhejiang CONBA PharmaceuticalLtd

Market Cap: CN¥10.7b

Engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China.

600572

CN¥4.35

7D

-2.0%

1Y

-4.8%

Tianjin Chase Sun PharmaceuticalLtd

Market Cap: CN¥11.0b

Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.

300026

CN¥3.66

7D

-2.4%

1Y

1.7%

Guizhou Xinbang Pharmaceutical

Market Cap: CN¥6.5b

Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.

002390

CN¥3.42

7D

-3.1%

1Y

0.6%

HARBIN GLORIA PHARMACEUTICALS

Market Cap: CN¥7.0b

Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China.

002437

CN¥3.11

7D

-7.4%

1Y

51.0%

Fuan Pharmaceutical (Group)

Market Cap: CN¥5.1b

Research and develops, produces, and sells chemical drugs in the People's Republic of China.

300194

CN¥4.29

7D

-2.9%

1Y

2.6%

Hunan Er-Kang Pharmaceutical

Market Cap: CN¥7.2b

Manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.

300267

CN¥3.49

7D

-4.4%

1Y

38.5%

Tiansheng Pharmaceutical Group

Market Cap: CN¥1.6b

Engages in the pharmaceutical manufacturing and circulation activities.

New

002872

CN¥4.89

7D

-6.1%

1Y

27.3%

Chongqing Lummy Pharmaceutical

Market Cap: CN¥4.6b

Engages in the research and development, manufacture, and sale of pharmaceutical products in China.

300006

CN¥4.31

7D

-2.5%

1Y

38.6%

Guizhou Yibai Pharmaceutical

Market Cap: CN¥3.2b

Researches, develops, produces, and sells pharmaceutical products in China.

600594

CN¥4.06

7D

-3.8%

1Y

13.7%

Qinghai Spring Medicinal Resources Technology

Market Cap: CN¥2.8b

Qinghai Spring Medicinal Resources Technology Co., Ltd.

New

600381

CN¥4.91

7D

-2.0%

1Y

63.7%

Dezhan Healthcare

Market Cap: CN¥8.8b

Engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China.

000813

CN¥4.31

7D

-1.1%

1Y

55.0%